During the past decade, Zentrum fuer klinische Forschung conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Zentrum fuer klinische Forschung" are "Cardiovascular Disease" (2 trials) and "Respiratory Syncytial Virus Infection Prevention" (1 trials). Many other conditions were trialed in "Zentrum fuer klinische Forschung" in a lesser frequency.

Most popular intervention types in "Zentrum fuer klinische Forschung" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials) and "Ad26.RSV.preF-based Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zentrum fuer klinische Forschung" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Zentrum fuer klinische Forschung". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Zentrum fuer klinische Forschung, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Zentrum fuer klinische Forschung, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".